Adage Capital Partners’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.2M | Sell |
816,715
-814,285
| -50% | -$77M | 0.13% | 158 |
|
|
2025
Q1 | $104M | Buy |
1,631,000
+1,292,575
| +382% | +$82.1M | 0.19% | 104 |
|
|
2024
Q4 | $15.7M | Buy |
+338,425
| New | +$15.7M | 0.03% | 495 |
|
|
2024
Q3 | – | Sell |
-175,000
| Closed | -$2.53M | – | 944 |
|
|
2024
Q2 | $2.53M | Hold |
175,000
| – | – | ﹤0.01% | 768 |
|
|
2024
Q1 | $2.82M | Sell |
175,000
-476,931
| -73% | -$7.67M | 0.01% | 751 |
|
|
2023
Q4 | $13M | Buy |
651,931
+225,000
| +53% | +$4.47M | 0.03% | 539 |
|
|
2023
Q3 | $6.96M | Buy |
426,931
+208,100
| +95% | +$3.39M | 0.02% | 623 |
|
|
2023
Q2 | $4.63M | Sell |
218,831
-18,100
| -8% | -$383K | 0.01% | 676 |
|
|
2023
Q1 | $4.76M | Buy |
236,931
+155,000
| +189% | +$3.11M | 0.01% | 713 |
|
|
2022
Q4 | $2.14M | Sell |
81,931
-349,885
| -81% | -$9.14M | 0.01% | 814 |
|
|
2022
Q3 | $4.41M | Buy |
+431,816
| New | +$4.41M | 0.01% | 795 |
|